The purpose of the current study is to evaluate the effect of preimplantation genetic screening (PGS) by next generation sequencing (NGS) compared to standard morphological assessment of embryos on pregnancy rates through a randomized controlled trial (RCT). All embryos will be vitrified and a single embryo transfer (SET) will be performed with either screened or unscreened embryos depending on randomization.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Enrollment
661
The VeriSeq PGS takes advantage of next-generation sequencing (NGS) technology to provide comprehensive, accurate screening of all 24 chromosomes for selection of euploid embryos.
Ongoing Pregnancy
Number of Participants with Ongoing Pregnancy at 20 Weeks Gestation
Time frame: Gestational Age of 20 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Fertility Treatment Center
Tempe, Arizona, United States
HRC Fertility
Encino, California, United States
Acacio Fertility Clinic
Laguna Niguel, California, United States
HRC Fertility Pasadena
Pasadena, California, United States
Fertility Specialists Medical Group
San Diego, California, United States
Reproductive Science Center of San Francisco Bay Area
San Ramon, California, United States
Colorado Center for Reproductive Medicine (CCRM)
Lonetree, Colorado, United States
Reproductive Associates of Delaware
Newark, Delaware, United States
CRM Orlando
Orlando, Florida, United States
Georgia Reproductive Specialists
Atlanta, Georgia, United States
...and 28 more locations